Data Science, AI, and Machine Learning in Drug Development
Herausgegeben von:
Yang HarryIntended to be a single source of information, this book covers a wide range of topics on the changing landscape of drug R&D, emerging applications of big data, AI and machine learning in drug development, and the build of robust data science organizations to drive biopharmaceutical digital transformations.
Oktober 2022, ca. 320 Seiten, Chapman & Hall/CRC Biostatistics Series, Englisch
Taylor and Francis
978-0-367-70807-8
Taylor and Francis
978-0-367-70807-8

